Literature DB >> 33718398

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review.

Anna Pia Delli Bovi1, Francesca Marciano1,2, Claudia Mandato3, Maria Anna Siano1, Marcella Savoia2, Pietro Vajro1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it remains still orphan of an adequate therapeutic strategy. Herein we focus on the interplay between oxidative stress (OS) and the other causal pathogenetic factors. Different reactive oxygen species (ROS) generators contribute to NAFLD inflammatory and fibrotic progression, which is quite strictly linked to the lipotoxic liver injury from fatty acids and/or a wide variety of their biologically active metabolites in the context of either a two-hit or a (more recent) multiple parallel hits theory. An antioxidant defense system is usually able to protect hepatic cells from damaging effects caused by ROS, including those produced into the gastrointestinal tract, i.e., by-products generated by usual cellular metabolic processes, normal or dysbiotic microbiota, and/or diet through an enhanced gut-liver axis. Oxidative stress originating from the imbalance between ROS generation and antioxidant defenses is under the influence of individual genetic and epigenetic factors as well. Healthy diet and physical activity have been shown to be effective on NAFLD also with antioxidant mechanisms, but compliance to these lifestyles is very low. Among several considered antioxidants, vitamin E has been particularly studied; however, data are still contradictory. Some studies with natural polyphenols proposed for NAFLD prevention and treatment are encouraging. Probiotics, prebiotics, diet, or fecal microbiota transplantation represent new therapeutic approaches targeting the gut microbiota dysbiosis. In the near future, precision medicine taking into consideration genetic or environmental epigenetic risk factors will likely assist in further selecting the treatment that could work best for a specific patient.
Copyright © 2021 Delli Bovi, Marciano, Mandato, Siano, Savoia and Vajro.

Entities:  

Keywords:  antioxidants; gut microbiota; metabolic syndrome; non-alcoholic fatty liver disease; obesity; obstructive sleep apnea syndrome; oxidative stress

Year:  2021        PMID: 33718398      PMCID: PMC7952971          DOI: 10.3389/fmed.2021.595371

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  161 in total

1.  Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury.

Authors:  Terrence C H Tan; Darrell H G Crawford; Lesley A Jaskowski; V Nathan Subramaniam; Andrew D Clouston; Denis I Crane; Kim R Bridle; Gregory J Anderson; Linda M Fletcher
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

Review 2.  D-livering the message: the importance of vitamin D status in chronic liver disease.

Authors:  Matthew T Kitson; Stuart K Roberts
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

Review 3.  Clinical implications of understanding the association between oxidative stress and pediatric NAFLD.

Authors:  Jake P Mann; Massimiliano Raponi; Valerio Nobili
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 3.869

4.  Lactobacillus rhamnosus GG decreases lipopolysaccharide-induced systemic inflammation in a gastrostomy-fed infant rat model.

Authors:  Liyan Zhang; Nan Li; Clotilde des Robert; Maozhong Fang; Kellym Liboni; Robert McMahon; Ricardo A Caicedo; Josef Neu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-05       Impact factor: 2.839

Review 5.  Nonalcoholic fatty liver disease: pathology and pathogenesis.

Authors:  Dina G Tiniakos; Miriam B Vos; Elizabeth M Brunt
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

6.  Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH).

Authors:  Andreas Erhardt; W Stahl; H Sies; F Lirussi; A Donner; D Häussinger
Journal:  Eur J Med Res       Date:  2011-02-24       Impact factor: 2.175

7.  Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD.

Authors:  Mayara Medeiros de Freitas Carvalho; Nara Nunes Lage; Alice Helena de Souza Paulino; Renata Rebeca Pereira; Letícia Trindade de Almeida; Tales Fernando da Silva; Cíntia Lopes de Brito Magalhães; Wanderson Geraldo de Lima; Marcelo Eustáquio Silva; Maria Lucia Pedrosa; Joyce Ferreira da Costa Guerra
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

Review 8.  Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Authors:  Agnes Görlach; Elitsa Y Dimova; Andreas Petry; Antonio Martínez-Ruiz; Pablo Hernansanz-Agustín; Anabela P Rolo; Carlos M Palmeira; Thomas Kietzmann
Journal:  Redox Biol       Date:  2015-08-28       Impact factor: 11.799

Review 9.  The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms.

Authors:  Chyntia Olivia Maurine Jasirwan; Cosmas Rinaldi Adithya Lesmana; Irsan Hasan; Andri Sanityosos Sulaiman; Rino Alvani Gani
Journal:  Biosci Microbiota Food Health       Date:  2019-05-08

10.  Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.

Authors:  Anton Gillessen; Hartmut H-J Schmidt
Journal:  Adv Ther       Date:  2020-02-17       Impact factor: 3.845

View more
  22 in total

1.  Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study.

Authors:  Liping Wang; Jinzhong Dong; Miao Xu; Li Li; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 2.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

3.  Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet.

Authors:  Nadiah S Alzahrani; Ghedeir M Alshammari; Afaf El-Ansary; Abu ElGasim A Yagoub; Musarat Amina; Ali Saleh; Mohammed Abdo Yahya
Journal:  Nutrients       Date:  2022-04-25       Impact factor: 6.706

Review 4.  Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease?

Authors:  Regina D Schnegelberger; Anna L Lang; Gavin E Arteel; Juliane I Beier
Journal:  Acta Pharm Sin B       Date:  2021-09-08       Impact factor: 11.413

5.  Intermittent Hypoxia Rewires the Liver Transcriptome and Fires up Fatty Acids Usage for Mitochondrial Respiration.

Authors:  Jonathan Gaucher; Guillaume Vial; Emilie Montellier; Maëlle Guellerin; Sophie Bouyon; Emeline Lemarie; Véronique Pelloux; Anne Bertrand; Karin Pernet-Gallay; Frederic Lamarche; Anne-Laure Borel; Claire Arnaud; Elise Belaidi; Karine Clément; Diane Godin Ribuot; Judith Aron-Wisnewsky; Jean-Louis Pépin
Journal:  Front Med (Lausanne)       Date:  2022-02-18

6.  The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH).

Authors:  Noel Salvoza; Chiara Bedin; Andrea Saccani; Claudio Tiribelli; Natalia Rosso
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 7.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

8.  Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways.

Authors:  Miguel Rebollo-Hernanz; Yolanda Aguilera; Maria A Martin-Cabrejas; Elvira Gonzalez de Mejia
Journal:  Antioxidants (Basel)       Date:  2022-01-08

9.  The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease.

Authors:  Guglielmina Chimienti; Antonella Orlando; Francesco Russo; Benedetta D'Attoma; Manuela Aragno; Eleonora Aimaretti; Angela Maria Serena Lezza; Vito Pesce
Journal:  Genes (Basel)       Date:  2021-09-18       Impact factor: 4.096

Review 10.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.